Brief report: randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia

The American Journal of Medicine

Volumn 87, Issue 5 SUPPL. 1, 1989, Pages

  Gangji, Diamon ^a,b,c   Jacobs, Frédérique ^a,b,c   de Jonckheer, Josine ^a,b,c   Coppens, Lyne ^a,b,c   Serruys, Elisabeth ^a,b,c   Hanotte, Françoise ^a,b,c   Motte, Serge ^a,b,c   Thys, Jean Pierre ^a,b,c  

^a ERASME HOSPITAL   (Belgium)

^b Cardiology   (Belgium)

^c Centre psychomédicosocial de Saint Gilles   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; GRAM NEGATIVE BACTERIUM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; SEPSIS; THROMBOCYTOPENIA; URINARY TRACT INFECTION; VOMITING;

ADMINISTRATION, ORAL; AGED; CIPROFLOXACIN; DRUG ADMINISTRATION SCHEDULE; GRAM-NEGATIVE BACTERIA; HUMAN; INFUSIONS, INTRAVENOUS; MIDDLE AGE; RANDOM ALLOCATION; SEPTICEMIA; SUPPORT, NON-U.S. GOV'T;

EID: 0024981604     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(89)90060-0     Document Type: Article

References (10)

1. Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa
2. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis
3. Quinolones in the treatment of serious infections
4. The acylampicillins: mezlocillin, piperacillin and azlocillin
5. Ceftadizine in the treatment of nosocomial sepsis
6. Comparison de l'efficacite du cefotaxime seul et de l'association cefazoline-tobramycine dans le treatment des septicemies a enterobacteries
7. Clinical experience with aztreonam in the treatment of gram-negative bacteremia
8. Gram-negative bacteria III Reassessment of etiology epidemiology and ecology in 612 patients
9. Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients
10. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses